Medical Diode Laser (S1Pro+, S1Pro K15, S1Pro N6, S1Pro N75)
Wuhan Pioon Technology Co., Ltd. · Decision date Sep 10, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on September 10, 2026 for K262426, a traditional 510(k) from Wuhan Pioon Technology Co., Ltd. covering the Medical Diode Laser under model designations S1Pro+, S1Pro K15, S1Pro N6 and S1Pro N75. The device falls under regulation 878.4810, product code GEX, in the General & Plastic Surgery specialty, with the same panel listed for review. The application was received July 16, 2026; SESE denotes clearance to market, not premarket approval.
The available FDA correspondence excerpt describes the S1Pro+ as intended for delivery of laser light to soft tissue in contact and non-contact modes, and states that the device's 980nm laser is generally indicated for incision, excision, vaporization, ablation, hemostasis or coagulation of soft tissue. The excerpt does not establish whether those indications extend to the K15, N6 and N75 configurations, nor does it give wavelengths, power settings, patient-selection criteria or treatment parameters; those details remain in the full FDA documents. No third-party review, combination product status or change control plan was recorded.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Sep 10, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262426
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Wuhan Pioon Technology Co., Ltd.
- Product code
- GEX
- Decision code
- SESE
- Decision date
- Sep 10, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Powered Laser Surgical Instrument.
- Applicant
- Wuhan Pioon Technology Co., Ltd.
- Product code
- GEX
- FDA device class
- 2
FDA decision timeline
K262426 received
Application receipt date recorded by FDA.
K262426 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code GEX
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Single Use Optical FiberK262886 | Quanta System Spa | 510(k) clearance | Nov 5, 2026 | FDA |
| Borze, Inc. | 510(k) clearance | Oct 30, 2026 | FDA | |
| Risu Medical Technology Co., Ltd. | 510(k) clearance | Oct 27, 2026 | FDA | |
| Sanhe PERFECTLASER Technology Co., Ltd. | 510(k) clearance | Oct 26, 2026 | FDA | |
| Beijing Sea Heart International Science and Technologyco.Ltd | 510(k) clearance | Oct 22, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Wuhan Pioon Technology Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Wuhan
Sources and methodology
- Original FDA record: K262426
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


